Compare VET & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VET | STAA |
|---|---|---|
| Founded | 1994 | 1982 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Ophthalmic Goods |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.5B |
| IPO Year | 2004 | 1995 |
| Metric | VET | STAA |
|---|---|---|
| Price | $11.85 | $24.11 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 9 |
| Target Price | $15.00 | ★ $22.81 |
| AVG Volume (30 Days) | ★ 1.4M | 1.1M |
| Earning Date | 05-06-2026 | 05-12-2026 |
| Dividend Yield | ★ 2.84% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.26 |
| Revenue | N/A | ★ $239,442,000.00 |
| Revenue This Year | $14.07 | $30.82 |
| Revenue Next Year | $3.40 | $8.41 |
| P/E Ratio | ★ N/A | $100.69 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.00 | $15.59 |
| 52 Week High | $14.82 | $35.87 |
| Indicator | VET | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 59.79 | 44.27 |
| Support Level | $11.14 | $22.91 |
| Resistance Level | $11.93 | $25.31 |
| Average True Range (ATR) | 0.34 | 1.38 |
| MACD | 0.03 | 0.30 |
| Stochastic Oscillator | 78.26 | 49.07 |
Vermilion Energy Inc is an international oil and gas-producing company. The company engages in full-cycle exploration and production programs that focus on the acquisition, exploration, and development of liquids-rich natural gas in Canada and conventional natural gas in Europe while optimizing low-decline oil assets. Its operating segments are: Canada, France, Netherlands, Germany, Ireland, Australia, and CEE, each representing the oil and gas exploration operations at its assets located in these regions. The company mainly derives revenue from the production and sale of petroleum and natural gas. The majority of its revenue is generated from Canada, where the company's operations are mainly focused on the Deep Basin trend in the West Pembina region of Alberta and on the Mica property.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.